These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31352709)

  • 1. Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study.
    Woo YS; Yoon BH; Jeon BH; Seo JS; Nam B; Lee SY; Jae YM; Jang SH; Eun HJ; Won SH; Lee K; Lee J; Bahk WM
    Clin Psychopharmacol Neurosci; 2019 Aug; 17(3):423-431. PubMed ID: 31352709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study.
    Woo YS; Park JE; Kim DH; Sohn I; Hwang TY; Park YM; Jon DI; Jeong JH; Bahk WM
    Psychiatry Investig; 2016 Jul; 13(4):458-67. PubMed ID: 27482249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.
    Iwata N; Ishigooka J; Naoi I; Matsumoto M; Kanamori Y; Nakamura H; Higuchi T
    CNS Drugs; 2020 Jan; 34(1):103-116. PubMed ID: 31883082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.
    Kawabe K; Horiuchi F; Ueno S
    Clin Neuropharmacol; 2013; 36(6):239-41. PubMed ID: 24201238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance.
    Bo Q; Wang X; Liu X; Sang H; Xun Z; Zhang R; Yang X; Deng H; Li K; Chen J; Sun M; Zhao G; Liu X; Cai D; Zhan G; Li J; Li H; Wang G
    BMC Psychiatry; 2023 Feb; 23(1):115. PubMed ID: 36810039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Safety and Efficacy of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 52-Week, Multicenter, Open-Label Extension Study.
    Saito T; Hyodo Y; Sakaguchi R; Nakamura H; Ishigooka J
    J Child Adolesc Psychopharmacol; 2022 Feb; 32(1):24-35. PubMed ID: 34612724
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.
    Iwata N; Ishigooka J; Kim WH; Yoon BH; Lin SK; Sulaiman AH; Cosca R; Wang L; Suchkov Y; Agarkov A; Watabe K; Matsui T; Sato T; Inoue Y; Higuchi T; Correll CU; Kane JM
    Schizophr Res; 2020 Jan; 215():408-415. PubMed ID: 31471246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies.
    Murasaki M; Inoue Y; Nakamura H; Kinoshita T
    Ann Gen Psychiatry; 2021 Sep; 20(1):41. PubMed ID: 34493318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.
    Miura I; Shiga T; Katsumi A; Kanno-Nozaki K; Mashiko H; Niwa S; Yabe H
    Hum Psychopharmacol; 2014 Mar; 29(2):199-202. PubMed ID: 24590545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.
    Garcia E; Robert M; Peris F; Nakamura H; Sato N; Terazawa Y
    CNS Drugs; 2009; 23(7):615-25. PubMed ID: 19552488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
    CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Follow-Up of Serum Prolactin Level in Schizophrenia Patients Treated with Blonanserin: A Case Series.
    Takahashi S; Suzuki M; Uchiyama M
    Psychiatry Investig; 2015 Oct; 12(4):566-8. PubMed ID: 26508971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study.
    Saito T; Sugimoto S; Sakaguchi R; Nakamura H; Ishigooka J
    J Child Adolesc Psychopharmacol; 2022 Feb; 32(1):12-23. PubMed ID: 35133884
    [No Abstract]   [Full Text] [Related]  

  • 16. Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study.
    Ohi K; Takai K; Kuramitsu A; Sugiyama S; Shioiri T
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110470. PubMed ID: 34740708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders.
    Kishi T; Matsuda Y; Matsunaga S; Mukai T; Moriwaki M; Tabuse H; Fujita K; Iwata N
    Neuropsychiatr Dis Treat; 2016; 12():3041-3049. PubMed ID: 27932884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance.
    Wu H; Wang X; Liu X; Sang H; Bo Q; Yang X; Xun Z; Li K; Zhang R; Sun M; Cai D; Deng H; Zhao G; Li J; Liu X; Zhan G; Chen J
    Front Psychiatry; 2022; 13():935769. PubMed ID: 36061293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up study of psychotic patients treated with blonanserin: a case series.
    Takahashi S; Suzuki M; Uchiyama M
    Asia Pac Psychiatry; 2013 Sep; 5(3):164-7. PubMed ID: 23857800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.